Search Results 181-190 of 15814 for GLP-1 agonist

  1. Pioglitazone and glimepiride (oral route) - Side effects & dosage - Mayo Clinic

    For patients switching from other diabetes medicines: Adults—At first, 1 tablet (pioglitazone 30 milligrams (mg) plus glimepiride 2 mg) once a day. Your doctor ...

  2. Analysis of Biomarkers in Type 1 Diabetes Mellitus - Mayo Clinic

    The purpose of this study is to develop a better blood test to diagnose early kidney injury in type 1 diabetes. Participation eligibility. Participant ...

  3. Ertugliflozin and metformin (oral route) - Side effects & dosage - Mayo Clinic

    This medicine does not help patients who have insulin-dependent or type 1 diabetes. Type 1 diabetic patients must use insulin injections. This medicine is ...

  4. Saxagliptin and dapagliflozin (oral route) - Mayo Clinic

    This helps lower the blood sugar level. This medicine does not help patients who have insulin-dependent or type 1 diabetes. Type 1 diabetic patients must use ...

  5. A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a ... Prior exposure to exenatide or other GLP-1R agonists. Prior exposure to ...

  6. Linagliptin and metformin (oral route) - Side effects & dosage - Mayo Clinic

    This medicine does not help patients who have insulin-dependent or type 1 diabetes. This medicine is available only with your doctor's prescription. This ...

  7. Glyburide, micronized (oral route) - Side effects & dosage - Mayo Clinic

    If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Acebutolol; Aminolevulinic Acid ...

  8. Glyburide and metformin (oral route) - Mayo Clinic

    If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Acebutolol; Aminolevulinic Acid ...

  9. Rosiglitazone and glimepiride (oral route) - Side effects & dosage - Mayo Clinic

    Type 1 diabetes—Should not be used in patients with these conditions. Diabetic macular edema (swelling of the back of the eye) or; Edema (fluid retention or ...

  10. Publications - Michelle A. Anderson, M.D. - Mayo Clinic

    PANCREATIC SAFETY IN STUDIES OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST ALBIGLUTIDE. Endocr Pract. 2019 Jul; 25 (7):698-716 Epub 2019 Mar 13. View ...